These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Neuroprotection of rat hippocampal slices exposed to oxygen-glucose deprivation by enrichment with docosahexaenoic acid and by inhibition of hydrolysis of docosahexaenoic acid-containing phospholipids by calcium independent phospholipase A2. Strokin M; Chechneva O; Reymann KG; Reiser G Neuroscience; 2006 Jun; 140(2):547-53. PubMed ID: 16563639 [TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of human myocardial phospholipase A2 from transplant recipients suffering from end-stage ischemic heart disease. Hazen SL; Gross RW Circ Res; 1992 Mar; 70(3):486-95. PubMed ID: 1537086 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of platelet-activating factor (PAF) acetylhydrolase by methyl arachidonyl fluorophosphonate potentiates PAF synthesis in thrombin-stimulated human coronary artery endothelial cells. Kell PJ; Creer MH; Crown KN; Wirsig K; McHowat J J Pharmacol Exp Ther; 2003 Dec; 307(3):1163-70. PubMed ID: 14560038 [TBL] [Abstract][Full Text] [Related]
32. Role of phospholipase A2 in the cytotoxic effects of oxalate in cultured renal epithelial cells. Kohjimoto Y; Kennington L; Scheid CR; Honeyman TW Kidney Int; 1999 Oct; 56(4):1432-41. PubMed ID: 10504495 [TBL] [Abstract][Full Text] [Related]
33. Effect of the phospholipase A2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat hearts. Sargent CA; Vesterqvist O; McCullough JR; Ogletree ML; Grover GJ J Pharmacol Exp Ther; 1992 Sep; 262(3):1161-7. PubMed ID: 1382129 [TBL] [Abstract][Full Text] [Related]